Patricio G. Schlottmann
YOU?
Author Swipe
View article: Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations
Practical Guidance on the Clinical Management of Ocular Adverse Events Associated with Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Latin American Expert Panel Recommendations Open
Multiple myeloma is a significant cause of mortality worldwide, and although changes in the treatment landscape have improved outcomes overall, many patients become refractory to standard therapies. In Latin America, outcomes are especiall…
View article: Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion Open
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
View article: Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema Open
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
View article: Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion Open
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
View article: Diagnostic Odyssey of More than 1000 Patients with Inherited Retinal Diseases
Diagnostic Odyssey of More than 1000 Patients with Inherited Retinal Diseases Open
Inherited retinal diseases (IRDs) encompass a diverse group of disorders characterized by varying visual impairment. Their diagnostic process is often referred to as an "odyssey" because of multiple challenges: (1) referrals to various spe…
View article: Clinical and Genetic Characterization of RDH12-Retinal Dystrophy in a South American Cohort
Clinical and Genetic Characterization of RDH12-Retinal Dystrophy in a South American Cohort Open
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures.
View article: Nationwide genetic analysis of more than 600 families with inherited eye diseases in Argentina
Nationwide genetic analysis of more than 600 families with inherited eye diseases in Argentina Open
Background: To conduct the first large-scale genetic analysis of inherited eye diseases (IED) in Argentina and describe the comprehensive genetic profile of a large cohort of patients. Methods: This is a retrospective study analyzing medic…
View article: Guía consensuada sobre diagnóstico y tratamiento de la degeneración macular asociada a la edad de la Sociedad Argentina de Retina y Vítreo
Guía consensuada sobre diagnóstico y tratamiento de la degeneración macular asociada a la edad de la Sociedad Argentina de Retina y Vítreo Open
Objective: The present document was developed by the Argentinian Vitreo-Retinal Society (SARyV) with the goal of offering recommendations in order to unify nomenclature, classification, diagnosis, and treatment of Age-Related Macular Degen…
View article: THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES Open
Purpose: To provide a concise overview for ophthalmologists and practicing retina specialists of available clinical evidence of manipulating the angiopoietin/tyrosine kinase with immunoglobulin-like and endothelial growth factor–like domai…
View article: Ophthalmic genetics in South America
Ophthalmic genetics in South America Open
South America comprises of heterogeneous topographies, populations, and health care systems. Therefore, it is not surprising to see differences among the countries regarding expertise, education, and practices of ophthalmic genetics for pa…
View article: <p>Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials</p>
Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials Open
The strongest predictors of DR response to ranibizumab at month 6 were baseline DR severity and DME quiescence at month 3. Eyes with the most robust early improvements had moderately severe or severe NPDR or PDR at baseline.
View article: OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Open
Purpose: This review aimed to determine the optimal management of retinal pigment epithelial detachments (PEDs) in neovascular age-related macular degeneration (nAMD) based on review of available evidence in the literature. Methods: A comp…
View article: New Treatment Modalities for Neovascular Age-Related Macular Degeneration
New Treatment Modalities for Neovascular Age-Related Macular Degeneration Open
Age-related macular degeneration (AMD) is considered one of the main causes of severe vision loss in older adults. The neovascular form (nAMD) is an advanced stage, which is responsible for the most severe vision loss. Vascular endothelial…
View article: Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery
Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery Open
We found low-quality evidence that MMC may be more effective in achieving long-term lower intraocular pressure than 5-FU. Further comparative research on MMC and 5-FU is needed to enhance reliability and validity of the results shown in th…